Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2009, p. 20-30, Vol. 29, No. 1
0270-7306/09/$08.00+0 doi:10.1128/MCB.00544-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
in Human Skeletal Muscle Cells
,
Min Kim,1,
Byoung-Soo Youn,2
Nam Seok Lee,2
Ji Woo Park,2
In Kyu Lee,3
Yun Sok Lee,4
Jae Bum Kim,4
Young Min Cho,1
Hong Kyu Lee,1 and
Kyong Soo Park1*
Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul 110-744, South Korea,1 AdipoGen Inc., College of Life Science and Biotechnology, Korea University, Rm 641-B, 1, 5-ka, Anam-dong, Sungbuk-ku, Seoul, South Korea,2 Department of Internal Medicine, Kyungpook National University, Daegu, South Korea,3 Research Center for Functional Cellulomics, Department of Biological Sciences, Seoul National University, Seoul 151-742, South Korea4
Received 4 April 2008/ Returned for modification 7 May 2008/ Accepted 10 October 2008
Oxidative stress plays an important role in the pathogenesis of insulin resistance and type 2 diabetes mellitus and in diabetic vascular complications. Thiazolidinediones (TZDs), a class of peroxisome proliferator-activated receptor
(PPAR
) agonists, improve insulin sensitivity and are currently used for the treatment of type 2 diabetes mellitus. Here, we show that TZD prevents oxidative stress-induced insulin resistance in human skeletal muscle cells, as indicated by the increase in insulin-stimulated glucose uptake and insulin signaling. Importantly, TZD-mediated activation of PPAR
induces gene expression of glutathione peroxidase 3 (GPx3), which reduces extracellular H2O2 levels causing insulin resistance in skeletal muscle cells. Inhibition of GPx3 expression prevents the antioxidant effects of TZDs on insulin action in oxidative stress-induced insulin-resistant cells, suggesting that GPx3 is required for the regulation of PPAR
-mediated antioxidant effects. Furthermore, reduced plasma GPx3 levels were found in patients with type 2 diabetes mellitus and in db/db/DIO mice. Collectively, these results suggest that the antioxidant effect of PPAR
is exclusively mediated by GPx3 and further imply that GPx3 may be a therapeutic target for insulin resistance and diabetes mellitus.
Published ahead of print on 20 October 2008.
Supplemental material for this article may be found at http://mcb.asm.org/.
These two authors contributed equally to this work.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»